As a member of the D-type cyclin family, cyclin D1 (CCND1) was a proto-oncogene and a good biomarker for tumor progression, found to be deregulated in several cancers, including RCC [10]. This evidence concerns the gene CCND1 and renal cell adenocarcinoma.